NASHVILLE, Tenn.--(BUSINESS WIRE)--Sarah Cannon Research Institute (SCRI). today announced the finalization of an agreement to collaborate scientifically with Yale Cancer Center (YCC) and Smilow Cancer Hospital at Yale-New Haven (SCH) to advance cancer research. “The integration of SCRI’s broad clinical trial knowledge with Yale’s translational and drug discovery expertise makes for a unique collaboration unrivaled in the field of cancer research,” said SCRI Chief Executive Officer Dee Anna Smit...  Full Article  @ BusinessWire - 1 year ago